About the Authors

Stephen J. McWilliam

Contributed equally to this work with: Stephen J. McWilliam, Daniel J. Antoine

Affiliation MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom

Daniel J. Antoine

Contributed equally to this work with: Stephen J. McWilliam, Daniel J. Antoine

d.antoine@liv.ac.uk

Affiliations MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom, Department of Medicine, Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

Venkata Sabbisetti

Affiliation Department of Medicine, Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

Mark A. Turner

Affiliation Department of Women’s and Children’s Health, Neonatal Unit, Liverpool Women’s Hospital, University of Liverpool, Liverpool, United Kingdom

Tracey Farragher

Affiliation Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom

Joseph V. Bonventre

Affiliation Department of Medicine, Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

B. Kevin Park

Affiliation MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom

Rosalind L. Smyth

Affiliation Institute of Child Health, Department of Women’s and Children’s Health, University of Liverpool, Liverpool, United Kingdom

Munir Pirmohamed

Affiliation MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom

Competing Interests

JVB is a co-inventor on KIM-1 patents assigned to Partners Healthcare and licensed to Sekisui, Johnson and Johnson and Biogenldec and a number of research reagent companies. The research reagent companies are MesoScale diagnostics, R&D systems, Cell biolabs Inc and Argutus Medical LTD (Molecules and methods for inhibiting shedding of KIM-1; Kidney injury-related molecules; Modulators of tissue regeneration). He is a consultant to Sekisui. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceived and designed the experiments: SJM DJA MT TF RLS BKP MP. Performed the experiments: SJM DJA VS. Analyzed the data: SJM DJA VS MT TF JVB RLS BKP MP. Contributed reagents/materials/analysis tools: DJA JVB BKP MP. Wrote the paper: SJM DJA VS MT JVB RLS BKP MP.